Layton AM - Search Results

1

Persistent acne in women : implications for the patient and for therapy.

Williams C, Layton AM. Williams C, et al. Among authors: layton am. Am J Clin Dermatol. 2006;7(5):281-90. doi: 10.2165/00128071-200607050-00002. Am J Clin Dermatol. 2006. PMID: 17007539 Review.

2

Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers.

Eady AE, Cove JH, Layton AM. Eady AE, et al. Among authors: layton am. Am J Clin Dermatol. 2003;4(12):813-31. doi: 10.2165/00128071-200304120-00002. Am J Clin Dermatol. 2003. PMID: 14640775 Review.

3

Systemic therapy for acne vulgaris.

Layton AM. Layton AM. Hosp Med. 2004 Feb;65(2):80-5. doi: 10.12968/hosp.2004.65.2.12064. Hosp Med. 2004. PMID: 14997773 Review.

4

European recommendations on the use of oral antibiotics for acne.

Dréno B, Bettoli V, Ochsendorf F, Layton A, Mobacken H, Degreef H; European Expert Group on Oral Antibiotics in Acne. Dréno B, et al. Eur J Dermatol. 2004 Nov-Dec;14(6):391-9. Eur J Dermatol. 2004. PMID: 15564203

5

Cutaneous infection with an Alternaria sp. in an immunocompetent host.

Williams C, Layton AM, Kerr K, Kibbler C, Barton RC. Williams C, et al. Among authors: layton am. Clin Exp Dermatol. 2008 Jul;33(4):440-2. doi: 10.1111/j.1365-2230.2007.02664.x. Epub 2008 Feb 28. Clin Exp Dermatol. 2008. PMID: 18312460

6

Can we define acne as a chronic disease? If so, how and when?

Gollnick HP, Finlay AY, Shear N; Global Alliance to Improve Outcomes in Acne. Gollnick HP, et al. Am J Clin Dermatol. 2008;9(5):279-84. doi: 10.2165/00128071-200809050-00001. Am J Clin Dermatol. 2008. PMID: 18717602 Review.

7

New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group.

Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, Shalita AR, Lozada VT, Berson D, Finlay A, Goh CL, Herane MI, Kaminsky A, Kubba R, Layton A, Miyachi Y, Perez M, Martin JP, Ramos-E-Silva M, See JA, Shear N, Wolf J Jr; Global Alliance to Improve Outcomes in Acne. Thiboutot D, et al. J Am Acad Dermatol. 2009 May;60(5 Suppl):S1-50. doi: 10.1016/j.jaad.2009.01.019. J Am Acad Dermatol. 2009. PMID: 19376456 Review.

8

The use of isotretinoin in acne.

Layton A. Layton A. Dermatoendocrinol. 2009 May;1(3):162-9. doi: 10.4161/derm.1.3.9364. Dermatoendocrinol. 2009. PMID: 20436884 Free PMC article.

9

IL-17: a key player in the P. acnes inflammatory cascade?

Thiboutot DM, Layton AM, Anne Eady E. Thiboutot DM, et al. Among authors: layton am. J Invest Dermatol. 2014 Feb;134(2):307-310. doi: 10.1038/jid.2013.400. J Invest Dermatol. 2014. PMID: 24424453 Free article.

10

Efficacy and safety of clindamycin phosphate 1.2%/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallel-group, phase III studies.

Dréno B, Bettoli V, Ochsendorf F, Layton AM, Perez M, Dakovic R, Gollnick H. Dréno B, et al. Among authors: layton am. Eur J Dermatol. 2014 Mar-Apr;24(2):201-9. doi: 10.1684/ejd.2014.2293. Eur J Dermatol. 2014. PMID: 24704684 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page